Recombinant human interleukin receptor antagonist influences serum chemokines in patients with rheumatoid arthritis

OBJECTIVE: To investigate the serum expressions of chemokines CCL2 and CCL3 in patients with rheumatoid arthritis (RA) who were treated with recombinant human interleukin 1 (IL-1) receptor antagonist (IL-1Ra). MATERIAL AND METHODS: Serum CCL2 and CCL3 were determined using an enzyme-linked immunosor...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Jun, Liu, Wei, Bao, Yi-Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Society of Experimental and Clinical Immunology 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440034/
https://www.ncbi.nlm.nih.gov/pubmed/26155119
http://dx.doi.org/10.5114/ceji.2014.43717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440034/
https://www.ncbi.nlm.nih.gov/pubmed/26155119
http://dx.doi.org/10.5114/ceji.2014.43717

Ejemplares similares